INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 18 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,509,377 | +4.9% | 13,507,000 | +3.8% | 0.41% | -6.4% |
| Q4 2022 | $12,877,281 | +318.6% | 13,007,000 | +311.2% | 0.44% | +601.6% |
| Q3 2022 | $3,076,000 | +0.3% | 3,163,000 | 0.0% | 0.06% | +51.2% |
| Q2 2022 | $3,068,000 | +0.6% | 3,163,000 | -4.7% | 0.04% | +46.4% |
| Q1 2022 | $3,050,000 | -3.0% | 3,320,000 | 0.0% | 0.03% | +64.7% |
| Q4 2021 | $3,144,000 | -94.6% | 3,320,000 | -94.9% | 0.02% | -92.8% |
| Q2 2021 | $58,191,000 | +40.3% | 64,548,000 | +28.8% | 0.24% | +12.9% |
| Q1 2021 | $41,465,000 | +199.4% | 50,109,000 | +186.3% | 0.21% | +198.6% |
| Q4 2020 | $13,850,000 | – | 17,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
| Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
| PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
| Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
| DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
| WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |